针对HER2-阳性阿坎托利性状细胞乳腺癌的新辅助疗法:一个病例报告
Jia Cong1, HyonSu Jo2,3, Na Zou4
1Department of Breast Surgery, Dalian Women and Children's Medical Group, Dalian, People's Republic of China.
The Journal of international medical research
|August 3, 2023
概括
阳性HER2的阿坎托利性状细胞癌 (ASCC) 是罕见的. 新辅助疗法在患有HER2阳性乳腺ASCC的患者中显示出有效性,在1.5年后没有复发.
科学领域:
- 在瘤学瘤学.
- 乳腺癌研究研究 乳腺癌研究
- 罕见的瘤 罕见的瘤
背景情况:
- 乳腺的阿坎托利性状细胞癌 (ASCC) 是一个不常见的诊断.
- HER2阳性乳腺ASCC异常罕见,对其特征的了解有限.
- 对HER2阳性乳腺ASCC的新辅助疗法的疗效在很大程度上仍未得到阐明.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558


